Long‐term outcomes of second treatment after initial transarterial chemoembolization in patients with hepatocellular carcinoma
Young‐Il Kim(Korea Institute of Ocean Science and Technology), Chang‐Min Kim(National Cancer Center), Hyun Beom Kim(Soonchunhyang University), Young Hwan Koh(National Cancer Center), Ju‐Hee Lee(Dongguk University), Tae Hyun Kim(Sookmyung Women's University), Seong Hoon Kim(National Cancer Center), Bo Hyun Kim(National Cancer Center), Joong‐Won Park(National Cancer Center), Heewon Kwak(National Cancer Center), In Joon Lee(National Cancer Center)
Cited by 10
Related Papers
Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study
|Liver International|2015|1.3k
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
|Journal of Clinical Oncology|2013|775
Predicting Radiation Pneumonitis After Chemoradiation Therapy for Lung Cancer: An International Individual Patient Data Meta-analysis
|International Journal of Radiation Oncology*Biology*Physics|2013|673